Epithelix
PrivateLast Round
Grant
Dec 1, 2020
Total Funding Raised
$146,100
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Epithelix is a biotechnology company that provides alternative in-vitro solutions to animal experimentation for evaluating the effects of drugs and the toxicity of chemical compounds on the human respiratory tract.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epithelix Comparables
Compare Epithelix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlveoliX AG | 86% | |
| ImmuONE | 84% | |
| Sartorius Aktiengesellschaft | 79% |
Epithelix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2020 | ||||
| Grant | Jun 18, 2008 | ||||
| Grant | Jun 18, 2007 | ||||
| Seed | Mar 1, 2006 |
Key People
Founding team and executive leadership
Epithelix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| W.A. de Vigier Foundation | Grant |
| Unitec | Seed |
| Fondation Dr. René Liechti | Grant |
| Foundation Eclosion | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 40% MoM, reaching 1.6K.
- Apr 15, 2026
Monthly visitors increased 2440% MoM, reaching 1.1K.
Epithelix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Epithelix's valuation, stock price, and market status.
Is Epithelix a public or private company?
Epithelix is a private company.
What is the current stock price of Epithelix?
Epithelix is a private company with no public stock price. No recent secondary market data is available.
How much is Epithelix worth (valuation)?
Valuation information for Epithelix is not publicly available.
Can I buy Epithelix stock?
Epithelix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Epithelix's last funding round?
Epithelix's most recent funding round was Grant on December 1, 2020.
Who are the main investors in Epithelix?
Key investors in Epithelix include Foundation Eclosion.
Will Epithelix IPO soon?
No public IPO plans have been announced for Epithelix.
How can I track Epithelix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epithelix's secondary market activity and sign up for updates.